Neurotensin (1-11) is an extended N-terminal fragment that retains structural contributions to the full neurotensin peptide. Its sequence supports studies of helix–turn formation and partial receptor engagement. Researchers employ it to contrast N-terminal and C-terminal roles in activity. The peptide aids structural dissection of neurotensin-family ligands.
1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More